Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

被引：0
|
作者：
Bumma, Naresh [1 ]
Reu, Frederic J. [1 ]
Samaras, Christy [1 ]
Duong, Hien K. [1 ]
Smith, Mitchell R. [1 ]
Valent, Jason [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Osteoporosis - Efficacy and safety of a bisphosphonate dosed once weekly
    Baran, D
    GERIATRICS, 2001, 56 (03) : 28 - 32
  • [22] Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus
    Quartuccio, Luca
    Rupolo, Maurizio
    Michieli, Mariagrazia
    De Vita, Salvatore
    RHEUMATOLOGY, 2014, 53 (02) : 381 - 382
  • [23] Safety Profile Of Bortezomib Impacts Survival Of Cardiac AL Amyloidosis
    Van de Wyngaert, Zoe
    Vanoutryve, Greg
    Herbaux, Charles
    Fouquet, Guillemette
    Demarquette, Helene
    Bonnet, Sarah
    Beauvais, David
    Guidez, Stephanie
    Lamblin, Nicolas
    Hachulla, Eric
    Launay, David
    Terriou, Louis
    Hivert, Benedicte
    Wemeau, Mathieu
    Leleu, Xavier
    BLOOD, 2013, 122 (21)
  • [24] Impact of Prior Therapies on the Safety and Efficacy of Once Weekly Selinexor, Bortezomib, and Dexamethasone Compared with Twice Weekly Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Results from the Boston Study
    Mateos, Maria
    Jagannath, Sundar
    Delimpasi, Sosana
    Simonova, Maryana
    Spicka, Ivan
    Pour, Ludek
    Kryachok, Irina
    Gavriatopoulou, Maria
    Dimopoulos, Meletios A.
    Pylypenko, Halyna
    Auner, Holger W.
    Leleu, Xavier
    Doronin, Vadim A.
    Usenko, Ganna
    Benjamin, Reuben
    Dolai, Tuphan Kanti
    Sinha, Dinesh Kumar
    Venner, Christopher P.
    Garg, Mamta
    Stevens, Don A.
    Quach, Hang
    Moreau, Philippe
    Levy, Moshe Y.
    Badros, Ashraf Z.
    Anderson, Larry D., Jr.
    Bahlis, Nizar J.
    Facon, Thierry
    Cavo, Michele
    Chai, Yi
    Arazy, Melina
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Richardson, Paul G.
    Grosicki, Sebastian
    BLOOD, 2020, 136
  • [25] Efficacy of the Combination of Bortezomib and Dexamethasone in Systemic AL Amyloidosis.
    Lamm, Wolfgang
    Willenbacher, Wolfgang
    Zojer, Niklas
    Muelduer, Ercan
    Ludwig, Heinz
    Lang, Alois
    Zielinski, Christoph C.
    Drach, Johannes
    BLOOD, 2009, 114 (22) : 1121 - 1121
  • [26] Efficacy and Safety of Once-Weekly versus Twice-Weekly Bortezomib in Patients with Hematologic Malignancies: A Meta-analysis with Trial Sequential Analysis
    Hu, Bin
    Zhou, Quan
    Hu, Yang-yang
    Zhuang, Lan
    Yi, Li-ping
    Cao, Jin-xia
    Li, Tian-qi
    Wang, Jun
    PHARMACOTHERAPY, 2019, 39 (06): : 697 - 708
  • [27] Efficacy and safety of exenatide once weekly: an overview of the DURATION trials
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (06) : 611 - 623
  • [28] Efficacy and safety of exenatide once weekly over 5 years
    MacConell, L.
    Maggs, D.
    Li, Y.
    Griffin, P.
    Wysham, C.
    DIABETOLOGIA, 2013, 56 : S393 - S393
  • [29] Efficacy and Safety of Exenatide Once Weekly in Italian Real Practice
    Disoteo, Olga E.
    Erpoli, Paolo
    Baruffaldi, Laura
    Chebat, Enrica
    Malighetti, Maria E.
    Manna, Raffaella
    Marenco, Paolo
    Rossi, Antonio
    Sali, Laura
    DIABETES, 2017, 66 : A627 - A627
  • [30] Efficacy of Once-Weekly Bortezomib with Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma
    Gut, Natalia
    Yucebay, Filiz
    Dempsey, Jessica
    Li, Junan
    Benson, Don M., Jr.
    BLOOD, 2018, 132
12345